Stock Research Report for Procter & Gamble Health Ltd
Stock score of Procter & Gamble Health Ltd moved up by 3 in 3 months on a 10 point scale (Source: Refinitiv). Get detailed report on Procter & Gamble Health Ltd by subscribing to ETPrime.
![Stock Reports Plus Stock Reports Plus](https://img.etimg.com/thumb/msid-83539106,width-462,height-284,imgsize-445470,resizemode-8,quality-100/stock-reports-plus.jpg)
Get 4000+ Stock Reports worth₹ 1,499* with ETPrimeat no extra cost for you
*As per competitive benchmarking of annual price. T&C apply
Make Investment decisions
with proprietary stock scores on earnings, fundamentals, relative valuation, risk and price momentum
Find new Trading ideas
with weekly updated scores and analysts forecasts on key data points
In-Depth analysis
of company and its peers through independent research, ratings, and market data
Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The Company operates through two segments: Pharmaceuticals and Chemicals. Its geographical segments include Domestic and Exports. Its Pharmaceutical segment consists of ethicals used in the treatment of cardiovascular and metabolic diseases, consumer healthcare products and vitamins-based formulations. The Pharmaceuticals segment has two business divisions: BioPharma and Consumer Health. Its Chemicals segment includes bulk drugs and pigments. It consists of two divisions: Pharma Chem Solutions and Performance Materials. The Pharm Chem Solutions division offers products and solutions, including active pharmaceutical ingredients, excipients. It offers products, such as vitamin E, guaizulene, thaiminedisulphide (TDS).